research use only
Cat.No.S1792
| Related Targets | Dehydrogenase HSP Transferase P450 (e.g. CYP17) PDE phosphatase PPAR Vitamin Carbohydrate Metabolism Mitochondrial Metabolism |
|---|---|
| Other HMG-CoA Reductase Inhibitors | Mevastatin SR-12813 Clinofibrate Cerivastatin sodium Dihydrolanosterol 7-ketocholesterol |
|
In vitro |
DMSO
: 83 mg/mL
(198.29 mM)
Ethanol : 83 mg/mL Water : Insoluble The solubility data above are all experimental results (not literature values). |
|
In vivo |
|||||
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.
Read more about Simvastatin (MK-733) solubility in DMSO or water
Read more about Simvastatin (MK-733) working concentrations for cell culture treatment
Simvastatin (MK-733) is a potent inhibitor of Cholesterol (20 mg/L), pancreatic cholesterol esterase enzyme (142.30 ± 5.67 μg/ml), Pancreatic cholesterol esterase (79.97 ± 24.84 μg/ml), CAMK1G (8.9 µM), TSSK1B (3.3 µM), -- (less than 20nM), HMG-CoA Reductase enzyme (0.00238 ± 0.00004 mg/mL), human liver microsomes (10.4 µM), rat liver microsomes (6.444 μM). Simvastatin (MK-733) exhibits the greatest inhibitory potency toward -- (IC50 = less than 20nM).
| Information | Simvastatin (MK-733) is a lipophilic HMGCR inhibitor. It affects RhoA signaling by blocking mevalonate, reducing cholesterol. |
|---|---|
|
Read more about Simvastatin (MK-733) IC50 for cell-based and cell-free assays |
|
| Primary Applications and Mechanism of Action | |
| Molecular Weight | 418.57 | Formula | C25H38O5 |
Storage (From the date of receipt) | |
|---|---|---|---|---|---|
| CAS No. | 79902-63-9 | Download SDF | Storage of Stock Solutions |
|
|
| Synonyms | MK 733 | Smiles | CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C | ||
Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.
Question 1:
Can you please advise if it has been tested effectively for in vivo use in mice? What solvent can be used to deliver this compound in vivo?
Answer:
This compound is an oral drug and a lot of studies report its use in mice. According to this paper (http://atvb.ahajournals.org/content/21/1/115.full), 0.5% Methyl-cellulose can be used as the vehicle.
Question 2:
If any specific protocols exist for in vitro use, specifically any steps required to activate it?
Answer:
This compound is supplied in an inactive form and requires treatment with NaOH in EtOH followed by neutralization to pH 7.2 for activation. Please find the details from the following reference: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2739764/.